We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis.
- Authors
Lim, Maria A.; Bence, Kendra K.; Sandesara, Ishani; Andreux, Pénélope; Auwerx, Johan; Ishibashi, Jeff; Seale, Patrick; Kalb, Robert G.
- Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal, neurodegenerative disease that causes death of motor neurons. ALS patients and mouse models of familial ALS display organismal level metabolic dysfunction, which includes increased energy expenditure despite decreased lean mass. The pathophysiological relevance of abnormal energy homeostasis to motor neuron disease remains unclear. Leptin is an adipocyte-derived hormone that regulates whole-animal energy expenditure. Here, we report that placing mutant superoxide dismutase 1 (SOD1) mice in a leptin-deficient background improves energy homeostasis and slows disease progression. Leptin-deficient mutant SOD1 mice possess increased bodyweight and fat mass, as well as decreased energy expenditure. These observations coincide with enhanced survival, improved strength and decreased motor neuron loss. These results suggest that altering whole-body energy metabolism in mutant SOD1 mice can mitigate disease progression. We propose that manipulations that increase fat mass and reduce energy expenditure will be beneficial in the setting of motor neuron disease.
- Publication
Human Molecular Genetics, 2014, Vol 23, Issue 18, p4995
- ISSN
0964-6906
- Publication type
Article
- DOI
10.1093/hmg/ddu214